CervoMed Inc.
CRVO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $56 | $80 | $20 |
| - Cash | $9 | $8 | $11 | $9 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $48 | $69 | $11 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$8 | -$7 | -$5 | -$7 |
| % Margin | -2,395.3% | – | – | – |
| Net Income | -$8 | -$6 | -$5 | -$7 |
| % Margin | -2,395.3% | – | – | – |
| EPS Diluted | -0.84 | -0.7 | -0.56 | -0.77 |
| % Growth | -20% | -25% | 27.3% | – |
| Operating Cash Flow | -$6 | -$7 | -$4 | -$8 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$6 | -$7 | -$4 | -$8 |